您的位置: 首页 > 农业专利 > 详情页

Use of a tuberculosis rv2386c protein in the manufacture of a medicament for the treatment or prevention of tuberculosis
专利权人:
GlaxoSmithKline Biologicals S.A.
发明人:
BROWN, James,METTENS, Pascal,MURPHY, Dennis
申请号:
ES09781057
公开号:
ES2685498T3
申请日:
2009.07.24
申请国别(地区):
ES
年份:
2018
代理人:
摘要:
The present invention is directed to a polypeptide which comprises: (i) an Rv2386c protein sequence (ii) a variant of an Rv2386c protein sequence or (iii) an immunogenic fragment of an Rv2386c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充